About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Dr. Silvia De Santis, Group leader Translational Imaging Biomarkers. Instituto de Neurociencias (CSIC-UMH), San Juan de Alicante, Spain
Abstract: Neuroinflammation and neurodegeneration are hot topics for brain research, and promising targets for the development of novel treatments with potential for intervention in pathological conditions like multiple sclerosis. Non-invasive biomarkers are needed to characterise both aspects of brain tissue, both in preclinical models and in humans. This talk will discuss recent advances from the group, going in the direction of developing new neuroimaging tools to understand brain microstructural trajectories linked to these cellular processes in both healthy ageing and degeneration, and the association between such trajectories, risk factors and favorable functional outcomes. To achieve this aim, the chosen framework is based on diffusion-weighted magnetic resonance imaging, validated through cell-specific manipulations and potentiated through artificial intelligence
Host: Dr. Deborah Pareto Onghena, Main researcher Neuroradiology, Vall Hebron Institut de Recerca (VHIR)
Online attendance: https://gencat.zoom.us/j/88526227387